Article
New York urologists appointed to new posts
New York’s Integrated Medical Professionals, PLLC and Weill Cornell Medical College have appointed urologists to new posts.
New York’s Integrated Medical Professionals, PLLC and Weill Cornell Medical College have appointed urologists to new posts.
Ross Bauer, MD, and Mark Chang, MD, are the newest partners at Integrated Medical Professionals, a multispecialty practice that includes Advanced Urology Centers of New York (AUCNY) and Advanced Radiation Centers of New York (ARC).
Dr. Bauer and Dr. Chang are based at AUCNY’s Rockland County office in West Nyack. Dr. Bauer specializes in adult general urology and is an attending at Nyack Hospital and Good Samaritan Hospital. He received his medical degree from SUNY at Buffalo School of Medicine and his undergraduate degree from James Madison University, Harrisonburg, VA.
Dr. Chang specializes in robotic and laparoscopic urologic surgery and general urology. Prior to joining AUCNY, he served as an attending at Mid-Hudson Urological Associates, Newburgh, NY, and established a robotic surgery program at St. Luke’s Cornwall Hospital, also in Newburgh. He currently does robotic surgery at Good Samaritan Hospital in Suffern, NY. Dr. Chang received his medical degree from Jefferson Medical College, Philadelphia, and undergraduate degree from Pennsylvania State University, University Park.
At Weill Cornell Medical College and New York-Presbyterian Hospital, the newly created Institute for Precision Medicine will be led by Mark Rubin, MD, a pathologist and prostate cancer expert who uses whole genomic sequencing in his laboratory to investigate DNA mutations that lead to disease, particularly prostate cancer. Dr. Rubin currently serves as vice chair for experimental pathology, director of Translational Research Laboratory Services, the Homer T. Hirst III Professor of Oncology, professor of pathology and laboratory medicine and professor of pathology in urology at Weill Cornell and is a pathologist at New York-Presbyterian/Weill Cornell.
The Institute for Precision Medicine is a cutting-edge translational medicine research hub that will explore the new frontier of precision medicine, offering optimal targeted, individualized treatment based on each patient's genetic profile, according to Weill Cornell. The institute's new genomic research discoveries will help develop novel, personalized medical therapies to be tested in innovative clinical trials, while also building a comprehensive biobank to improve research and patient care.
